Gregg Griner

Orrick, Herrington & Sutcliffe LLP

+ Follow Contact

Latest Posts › Capital Raising

Share:

Life Sciences Snapshot – A Quarterly Report on Financing Trends – Q2 2023

This report series examines quarterly trends in life sciences venture investment. Key findings for Q1 2023 include: • Life sciences VC deal value totaled $5.0 billion across 364 deals, representing a 40.9% decline in value...more

4/26/2023 / Capital Markets , Capital Raising , Corporate Financing , Life Sciences , Startups , Technology Sector , Valuation , Venture Capital

Life Sciences Snapshot – A Quarterly Report on Financing Trends – Q1 2023

This report series examines quarterly trends in life sciences venture investment. Key findings for Q4 2022 include: • Deal value reached $7.1 billion in Q4 across 392 deals, bringing the 2022 annual total to $38.0 billion...more

2/14/2023 / Capital Raising , Corporate Counsel , Financial Markets , Initial Public Offering (IPO) , Life Sciences , Mergers , Pharmaceutical Industry , Startups , Venture Capital

Life Sciences Snapshot – A Quarterly Report on Financing Trends – Q3 2021

This edition of Orrick’s life sciences publication series reviews the key drivers of venture investment in the life sciences industry, which is proceeding at a record pace thus far in 2021. Key findings include: Investment...more

7/22/2021 / Capital Markets , Capital Raising , Corporate Financing , Initial Public Offering (IPO) , Life Sciences , Pharmaceutical Industry , Popular , Private Equity , Special Purpose Acquisition Companies (SPACs) , Venture Capital

3 Results

View per page

Page: of 1